Schedule 13G ownership disclosure

IMAGENEBIO INC

Common Stock, par value $0.001 per share · CUSIP: 45175G207

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • BIOTECHNOLOGY VALUE FUND L P

    Shares: 415,765.00 · Class: 3.7%

  • BVF I GP LLC

    Shares: 415,765.00 · Class: 3.7%

  • BIOTECHNOLOGY VALUE FUND II LP

    Shares: 325,596.00 · Class: 2.9%

  • BVF II GP LLC

    Shares: 325,596.00 · Class: 2.9%

  • Biotechnology Value Trading Fund OS LP

    Shares: 44,578.00 · Class: 0.4%

  • BVF Partners OS Ltd.

    Shares: 44,578.00 · Class: 0.4%

  • BVF GP HOLDINGS LLC

    Shares: 741,361.00 · Class: 6.6%

  • BVF PARTNERS L P/IL

    Shares: 802,102.00 · Class: 7.2%

  • BVF INC/IL

    Shares: 802,102.00 · Class: 7.2%

  • LAMPERT MARK N

    Shares: 802,102.00 · Class: 7.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000921895-25-003102
Form type
SCHEDULE 13G/A
Filer
BIOTECHNOLOGY VALUE FUND L P
CIK
CIK 918923
Filed
Nov 14, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub